Výsledky vyhledávání

Akademický článek

Fc-GDF15 glyco-engineering and receptor binding affinity optimization for body weight regulation.

Autor: Fung E; BioMedicine Design, Pfizer Inc., 610 N Main Street, Cambridge, MA, USA., Kang L; Internal Medicine Research Unit, Pfizer Inc., 1 Portland Street, Cambridge, MA, USA., Sapashnik D; BioMedicine Design, Pfizer Inc., 610 N Main Street, Cambridge, MA, USA., Benard S; BioMedicine Design, Pfizer Inc., 610 N Main Street, Cambridge, MA, USA., Sievers A; BioMedicine Design, Pfizer Inc., 610 N Main Street, Cambridge, MA, USA., Liu Y; BioMedicine Design, Pfizer Inc., 610 N Main Street, Cambridge, MA, USA., Yan G; BioMedicine Design, Pfizer Inc., 610 N Main Street, Cambridge, MA, USA., Zhou J; BioMedicine Design, Pfizer Inc., 610 N Main Street, Cambridge, MA, USA., Rodriguez L; BioMedicine Design, Pfizer Inc., 610 N Main Street, Cambridge, MA, USA., Ma W; BioMedicine Design, Pfizer Inc., 610 N Main Street, Cambridge, MA, USA.; Sanofi Research and Development, Sanofi North America, Framingham, MA, USA., Stochaj WR; BioMedicine Design, Pfizer Inc., 610 N Main Street, Cambridge, MA, USA., LaVallie E; BioMedicine Design, Pfizer Inc., 610 N Main Street, Cambridge, MA, USA., Wroblewska L; BioMedicine Design, Pfizer Inc., 610 N Main Street, Cambridge, MA, USA., Kelleher K; BioMedicine Design, Pfizer Inc., 610 N Main Street, Cambridge, MA, USA., Tam A; BioMedicine Design, Pfizer Inc., 610 N Main Street, Cambridge, MA, USA., Bezy O; Internal Medicine Research Unit, Pfizer Inc., 1 Portland Street, Cambridge, MA, USA.; Cellarity, Cambridge, MA, USA., Breen D; Internal Medicine Research Unit, Pfizer Inc., 1 Portland Street, Cambridge, MA, USA., Chabot JR; BioMedicine Design, Pfizer Inc., 610 N Main Street, Cambridge, MA, USA., He T; BioMedicine Design, Pfizer Inc., 610 N Main Street, Cambridge, MA, USA.; JOINN Biologics US Inc, Richmond, CA, USA., Lin L; BioMedicine Design, Pfizer Inc., 610 N Main Street, Cambridge, MA, USA., Wu Z; Internal Medicine Research Unit, Pfizer Inc., 1 Portland Street, Cambridge, MA, USA., Mosyak L; BioMedicine Design, Pfizer Inc., 610 N Main Street, Cambridge, MA, USA. Lidia.Mosyak@pfizer.com.

Publikováno v: Scientific reports [Sci Rep] 2021 Apr 26; Vol. 11 (1), pp. 8921. Date of Electronic Publication: 2021 Apr 26.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Discovery and optimization of a novel anti-GUCY2c x CD3 bispecific antibody for the treatment of solid tumors.

Autor: Root AR; BioMedicine Design, Pfizer Inc ., Cambridge, MA, USA., Guntas G; BioMedicine Design, Pfizer Inc ., Cambridge, MA, USA., Katragadda M; BioMedicine Design, Pfizer Inc ., Cambridge, MA, USA., Apgar JR; BioMedicine Design, Pfizer Inc ., Cambridge, MA, USA., Narula J; BioMedicine Design, Pfizer Inc ., Cambridge, MA, USA., Chang CS; BioMedicine Design, Pfizer Inc ., Cambridge, MA, USA., Hanscom S; BioMedicine Design, Pfizer Inc ., Cambridge, MA, USA., McKenna M; BioMedicine Design, Pfizer Inc ., Cambridge, MA, USA., Wade J; BioMedicine Design, Pfizer Inc ., Cambridge, MA, USA., Meade C; BioMedicine Design, Pfizer Inc ., Cambridge, MA, USA., Ma W; BioMedicine Design, Pfizer Inc ., Cambridge, MA, USA., Guo Y; BioMedicine Design, Pfizer Inc ., Cambridge, MA, USA., Liu Y; BioMedicine Design, Pfizer Inc ., Cambridge, MA, USA., Duan W; BioMedicine Design, Pfizer Inc ., Cambridge, MA, USA., Hendershot C; BioMedicine Design, Pfizer Inc ., Cambridge, MA, USA., King AC; BioMedicine Design, Pfizer Inc ., Cambridge, MA, USA., Zhang Y; BioMedicine Design, Pfizer Inc ., Cambridge, MA, USA., Sousa E; BioMedicine Design, Pfizer Inc ., Cambridge, MA, USA., Tam A; BioMedicine Design, Pfizer Inc ., Cambridge, MA, USA., Benard S; BioMedicine Design, Pfizer Inc ., Cambridge, MA, USA., Yang H; BioMedicine Design, Pfizer Inc ., Cambridge, MA, USA., Kelleher K; BioMedicine Design, Pfizer Inc ., Cambridge, MA, USA., Jin F; BioMedicine Design, Pfizer Inc ., Cambridge, MA, USA., Piche-Nicholas N; BioMedicine Design, Pfizer Inc ., Cambridge, MA, USA., Keating SE; BioMedicine Design, Pfizer Inc ., Dublin, IE, USA., Narciandi F; BioMedicine Design, Pfizer Inc ., Dublin, IE, USA., Lawrence-Henderson R; BioMedicine Design, Pfizer Inc ., Andover, MA, USA., Arai M; BioMedicine Design, Pfizer Inc ., Cambridge, MA, USA., Stochaj WR; BioMedicine Design, Pfizer Inc ., Cambridge, MA, USA., Svenson K; BioMedicine Design, Pfizer Inc ., Cambridge, MA, USA., Mosyak L; BioMedicine Design, Pfizer Inc ., Cambridge, MA, USA., Lam K; BioMedicine Design, Pfizer Inc ., Andover, MA, USA., Francis C; BioMedicine Design, Pfizer Inc ., Andover, MA, USA., Marquette K; BioMedicine Design, Pfizer Inc ., Cambridge, MA, USA., Wroblewska L; BioMedicine Design, Pfizer Inc ., Cambridge, MA, USA., Zhu HL; BioMedicine Design, Pfizer Inc ., Andover, MA, USA., Sheehan AD; BioMedicine Design, Pfizer Inc ., Dublin, IE, USA., LaVallie ER; BioMedicine Design, Pfizer Inc ., Cambridge, MA, USA., D'Antona AM; BioMedicine Design, Pfizer Inc ., Cambridge, MA, USA., Betts A; BioMedicine Design, Pfizer Inc ., Cambridge, MA, USA., King L; BioMedicine Design, Pfizer Inc ., Andover, MA, USA., Rosfjord E; Oncology Research & Development, Pfizer Inc ., Pearl River, NY, USA., Cunningham O; BioMedicine Design, Pfizer Inc ., Dublin, IE, USA., Lin L; BioMedicine Design, Pfizer Inc ., Cambridge, MA, USA., Sapra P; Oncology Research & Development, Pfizer Inc ., Pearl River, NY, USA., Tchistiakova L; BioMedicine Design, Pfizer Inc ., Cambridge, MA, USA., Mathur D; Oncology Research & Development, Pfizer Inc ., Pearl River, NY, USA., Bloom L; BioMedicine Design, Pfizer Inc ., Cambridge, MA, USA.

Publikováno v: MAbs [MAbs] 2021 Jan-Dec; Vol. 13 (1), pp. 1850395.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání